Digital healthcare platform Clinikally has secured $2.6 million in a new round from Y Combinator, Tribe Capital, Goodwater Capital, Sequoia Scout Fund, and Rebel Fund.
Some prominent angel investors, including Arash Ferdowsi, Kunal Shah, Austen Allred, Qasar Younis, Alagu Periyannan, Tanay Tandon, Deepika Bodapati, and James Beshara, participated in the funding.
It was a part of Y Combinator’s summer 2022 batch.
Arjun Soin founded Clinikally in late 2021 to connect consumers with licensed dermatology practitioners, addressing individual clinical requirements related to various conditions like acne, hair loss, hyperpigmentation, eczema, rosacea, and melasma, among others. The company has also introduced a feature that automatically generates treatment plans based on condition-specific diagnostics and questionnaires.
The Gurugram-based company asserts that it has assisted more than 450,000 users across 500 cities.
In terms of products, Clinikally’s offerings compete or overlap with those of 1mg, Netmeds, and Pharmeasy. When it comes to teleconsultations, it faces competition from Practo and MediBuddy, while Apollo Online offers both products and teleconsultations.
Clinikally generates revenue from two sources: B2C, which includes a multi-brand online pharmacy and telehealth services, and B2B2C, a private label exclusively available at physical clinics.
Before this, Clinikally had secured $500,000 in funding in July 2022 and had the support of individuals such as Shutterstock CEO and founder Jon Oringer’s Parento Holdings, as well as ReNew Power founder Sumant Sinha, among others.
